Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help

C. Fayolle, Ussama M. Abdel-Motal, L. Berg, E. Deriaud, M. Jondal, C. Leclerc

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In several experimental models, synthetic peptides were shown to activate efficiently cytotoxic T-lymphocyte (CTL) responses and therefore represent an attractive strategy to develop new vaccines. However, the mechanisms by which they induce CTL responses are not yet fully understood. Several studies using 15-16-mer peptides previously demonstrated that CD4+ helper T cells are required to induce optimal CTL responses with synthetic peptides. However, recently, it was suggested that shorter 8-12-mer peptides could have an increased ill vivo immunogenicity. In the present study, we therefore investigated if such optimal-length peptides still require CD4+ T-cell help to activate CTL responses. To address this question, three synthetic peptides containing different viral CTL epitopes were injected into mice depleted of CD4+ or CD8+ T cells using specific monoclonal antibodies or into mice genetically deficient in those T-cell populations. Our results clearly established that activation of CTL responses by those short optimal peptides does not require CD4+ T-cell help and therefore suggested that high-density binding of peptides to major histocompatibility complex class I molecules on the surface of antigen-presenting cells is required for direct activation of CD8+ T cells, independently of CD4+ T-cell help.

Original languageEnglish
Pages (from-to)41-45
Number of pages5
JournalImmunology
Volume89
Issue number1
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Cytotoxic T-Lymphocytes
T-Lymphocytes
Peptides
T-Lymphocyte Epitopes
Antigen-Presenting Cells
Surface Antigens
Helper-Inducer T-Lymphocytes
Major Histocompatibility Complex
Theoretical Models
Vaccines
Monoclonal Antibodies
Population

ASJC Scopus subject areas

  • Immunology

Cite this

Fayolle, C., Abdel-Motal, U. M., Berg, L., Deriaud, E., Jondal, M., & Leclerc, C. (1996). Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help. Immunology, 89(1), 41-45.

Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help. / Fayolle, C.; Abdel-Motal, Ussama M.; Berg, L.; Deriaud, E.; Jondal, M.; Leclerc, C.

In: Immunology, Vol. 89, No. 1, 1996, p. 41-45.

Research output: Contribution to journalArticle

Fayolle, C, Abdel-Motal, UM, Berg, L, Deriaud, E, Jondal, M & Leclerc, C 1996, 'Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help', Immunology, vol. 89, no. 1, pp. 41-45.
Fayolle, C. ; Abdel-Motal, Ussama M. ; Berg, L. ; Deriaud, E. ; Jondal, M. ; Leclerc, C. / Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help. In: Immunology. 1996 ; Vol. 89, No. 1. pp. 41-45.
@article{ded3b303881e4ee6b381e63189b289d8,
title = "Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help",
abstract = "In several experimental models, synthetic peptides were shown to activate efficiently cytotoxic T-lymphocyte (CTL) responses and therefore represent an attractive strategy to develop new vaccines. However, the mechanisms by which they induce CTL responses are not yet fully understood. Several studies using 15-16-mer peptides previously demonstrated that CD4+ helper T cells are required to induce optimal CTL responses with synthetic peptides. However, recently, it was suggested that shorter 8-12-mer peptides could have an increased ill vivo immunogenicity. In the present study, we therefore investigated if such optimal-length peptides still require CD4+ T-cell help to activate CTL responses. To address this question, three synthetic peptides containing different viral CTL epitopes were injected into mice depleted of CD4+ or CD8+ T cells using specific monoclonal antibodies or into mice genetically deficient in those T-cell populations. Our results clearly established that activation of CTL responses by those short optimal peptides does not require CD4+ T-cell help and therefore suggested that high-density binding of peptides to major histocompatibility complex class I molecules on the surface of antigen-presenting cells is required for direct activation of CD8+ T cells, independently of CD4+ T-cell help.",
author = "C. Fayolle and Abdel-Motal, {Ussama M.} and L. Berg and E. Deriaud and M. Jondal and C. Leclerc",
year = "1996",
language = "English",
volume = "89",
pages = "41--45",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help

AU - Fayolle, C.

AU - Abdel-Motal, Ussama M.

AU - Berg, L.

AU - Deriaud, E.

AU - Jondal, M.

AU - Leclerc, C.

PY - 1996

Y1 - 1996

N2 - In several experimental models, synthetic peptides were shown to activate efficiently cytotoxic T-lymphocyte (CTL) responses and therefore represent an attractive strategy to develop new vaccines. However, the mechanisms by which they induce CTL responses are not yet fully understood. Several studies using 15-16-mer peptides previously demonstrated that CD4+ helper T cells are required to induce optimal CTL responses with synthetic peptides. However, recently, it was suggested that shorter 8-12-mer peptides could have an increased ill vivo immunogenicity. In the present study, we therefore investigated if such optimal-length peptides still require CD4+ T-cell help to activate CTL responses. To address this question, three synthetic peptides containing different viral CTL epitopes were injected into mice depleted of CD4+ or CD8+ T cells using specific monoclonal antibodies or into mice genetically deficient in those T-cell populations. Our results clearly established that activation of CTL responses by those short optimal peptides does not require CD4+ T-cell help and therefore suggested that high-density binding of peptides to major histocompatibility complex class I molecules on the surface of antigen-presenting cells is required for direct activation of CD8+ T cells, independently of CD4+ T-cell help.

AB - In several experimental models, synthetic peptides were shown to activate efficiently cytotoxic T-lymphocyte (CTL) responses and therefore represent an attractive strategy to develop new vaccines. However, the mechanisms by which they induce CTL responses are not yet fully understood. Several studies using 15-16-mer peptides previously demonstrated that CD4+ helper T cells are required to induce optimal CTL responses with synthetic peptides. However, recently, it was suggested that shorter 8-12-mer peptides could have an increased ill vivo immunogenicity. In the present study, we therefore investigated if such optimal-length peptides still require CD4+ T-cell help to activate CTL responses. To address this question, three synthetic peptides containing different viral CTL epitopes were injected into mice depleted of CD4+ or CD8+ T cells using specific monoclonal antibodies or into mice genetically deficient in those T-cell populations. Our results clearly established that activation of CTL responses by those short optimal peptides does not require CD4+ T-cell help and therefore suggested that high-density binding of peptides to major histocompatibility complex class I molecules on the surface of antigen-presenting cells is required for direct activation of CD8+ T cells, independently of CD4+ T-cell help.

UR - http://www.scopus.com/inward/record.url?scp=0029791235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029791235&partnerID=8YFLogxK

M3 - Article

VL - 89

SP - 41

EP - 45

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 1

ER -